Clinical Trial

Jin-shui Huan-xian Formula for Retarding the Decline of Pulmonary Function in IPF

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study is to evaluate the clinical efficacy and safety of Jin-shui Huan-xian Formula in retarding the decline of pulmonary function in IPF, generate high - quality clinical evidence, and establish a treatment plan of Jin-shui Huan-xian Formula for retarding the decline of pulmonary function in Idiopathic Pulmonary Fibrosis（IPF）
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-03-31; most recent amendment 2025-07-31.
Trial Details
NCT Number NCT06914713
Lead Sponsor Henan University of Traditional Chinese Medicine
Conditions Idiopathic Pulmonary Fibrosis(IPF)
Enrollment 384 participants
Start Date 2025-08-01
Primary Completion 2028-06-30 (estimated)
Study Completion 2028-11-30 (estimated)
Updated on ClinicalTrials.gov 2025-08-05